Furthermore, BBR reduces the activation of the NF-κB pathway via enhancing IκBα and inhibits the elevated phosphorylation of c-Fos/Jun in the scratched cancer cells MDA-MB-231 (56). The gene discussed is NFKB1; the disease is cancer.